Angrit Stachs

Dr. Angrit Stachs

Angrit Stachs

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2015 in Ultrasound International Open
Verified
Journal Article
Open access
PDF file
ASAngrit Stachs
Angrit Stachs
ATA. Tra-Ha Thi
A. Tra-Ha Thi
MDM. Dieterich
M. Dieterich
JSJ. Stubert
J. Stubert
SHS. Hartmann
S. Hartmann
BGB. Gerber
B. Gerber
Purpose: To evaluate the accuracy of axillary ultrasound (AUS) in detecting nodal metastasis in patients with early-stage breast cancer and to identify AUS features with high predictive power. Materials and Methods: Prospective single-center preliminary study in 105 patients with a primary diagnosis of breast cancer and clinically negative axilla. AUS was performed using a 12 MHz linear-array transducer before ultrasound-guided needle biopsy. Nodal characteristics (shape, longitudinal-transverse [LT] axis ratio, margins, cortical thickness, hyperechoic hilum) were correlated with histopathological nodal status after SLNB or axillary lymph node dissection (ALND). Results: Nodal metastases were present in 42/105 patients (40.0%). Univariate analyses showed that absence of hyperechoic hilum, round shape, LT axis ratio3 mm were associated with lymph node metastasis. Multivariate logistic regression analysis revealed cortical thickness > 3 mm as an independent predictive parameter for nodal involvement. Sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 66.7, 74.6, 63.6, 77.0% and 71.4% respectively when cortical thickness > 3 mm was applied as the criterion for AUS positivity. Axillary tumor volume was low in patients with pT1/2 tumors and negative AUS, since only 3.2% of patients had > 2 metastatic lymph nodes. Conclusion: Cortical thickness>3 mm is a reliable predictor of nodal metastatic involvement. Negative AUS does not exclude lymph node metastases, but extensive axillary tumor volume is rare.

1 April 2016 in The Breast
Verified
Journal Article
Closed access
MLM. Lange
M. Lange
TRT. Reimer
T. Reimer
SHS. Hartmann
S. Hartmann
ÄGÄ. Glass
Ä. Glass
ASAngrit Stachs
Angrit Stachs

1 December 2016 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
ASAngrit Stachs
Angrit Stachs
APAlexander Pandjaitan
Alexander Pandjaitan
AMAnnett Martin
Annett Martin
JSJohannes Stubert
Johannes Stubert
SHSteffi Hartmann
Steffi Hartmann
ÄGÄnne Glass
Änne Glass

7 May 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
KSKatharina Sterenczak
Katharina Sterenczak
NSNadine Stache
Nadine Stache
SBSebastian Bohn
Sebastian Bohn
SAStephan Allgeier
Stephan Allgeier
BKBernd Köhler
Bernd Köhler
ASAngrit Stachs
Angrit Stachs
During breast cancer therapy, paclitaxel and trastuzumab are both associated with adverse effects such as chemotherapy-induced peripheral neuropathy and other systemic side effects including ocular complications. Corneal nerves are considered part of the peripheral nervous system and can be imaged non-invasively by confocal laser scanning microscopy (CLSM) on the cellular level. Thus, in vivo CLSM imaging of structures of the corneal subbasal nerve plexus (SNP) such as sensory nerves or dendritic cells (DCs) can be a powerful tool for the assessment of corneal complications during cancer treatment. During the present study, the SNP of a breast cancer patient was analyzed over time by using large-scale in vivo CLSM in the course of paclitaxel and trastuzumab therapy. The same corneal regions could be re-identified over time. While the subbasal nerve morphology did not alter significantly, a change in dendritic cell density and an additional local burst within the first 11 weeks of therapy was detected, indicating treatment-mediated corneal inflammatory processes. Ocular structures such as nerves and dendritic cells could represent useful biomarkers for the assessment of ocular adverse effects during cancer therapy and their management, leading to a better visual prognosis.

24 March 2015 in Aesthetic Surgery Journal
Verified
Journal Article
Open access
PDF file
ASAngrit Stachs
Angrit Stachs
MDMax Dieterich
Max Dieterich
SHSteffi Hartmann
Steffi Hartmann
JSJohannes Stubert
Johannes Stubert
TRToralf Reimer
Toralf Reimer
BGBernd Gerber
Bernd Gerber
Implant rupture as a late complication of breast implant surgery is often a silent phenomenon that is difficult to diagnose. Sonoelastography is a new ultrasound-based technique that allows assessment of tissue elasticity. This study was undertaken to evaluate elastographic findings in normal and ruptured breast implants. This prospective study included 28 implants in 16 patients, all of whom underwent high-resolution ultrasound and real-time elastography. The diagnosis of implant rupture was confirmed by surgery. Implant rupture was diagnosed in 5 out of 28 implants (17.9%). In those patients with ruptured implants, 3 had no symptoms, 1 presented with pain, and 1 complained of ipsilateral axillary lymph node swelling. Implants with a homogenous anechoic interior were considered to be intact. Ultrasound findings indicating implant rupture included multiple parallel echogenic lines in the implant interior in 2 cases and a mix of hyperechoic and hypoechoic masses in 3 cases. The feasibility of real-time elastography of implants was demonstrated in all cases. Elastograms of intact implants revealed a typical blue-green-red pattern familiar from cystic lesions. In all 5 ruptured implants, elastography revealed yellow-green figures without typical layering. To the authors’ knowledge this is the first series to combine high-resolution ultrasound with real-time elastography for the diagnosis of implant rupture. Since there are distinct differences between elastograms of intact and ruptured implants, addition of real-time elastography to conventional ultrasound may improve implant surveillance and obviate the need for magnetic resonance imaging. 3 Therapeutic

11 May 2022 in Cancers
Verified
Journal Article
Open access
PDF file
GSGesche Schultek
Gesche Schultek
BGBernd Gerber
Bernd Gerber
TRToralf Reimer
Toralf Reimer
JSJohannes Stubert
Johannes Stubert
SHSteffi Hartmann
Steffi Hartmann
ASAngrit Stachs
Angrit Stachs
Background: Radiological underestimation of the actual tumor size is a relevant problem in reaching negative margins in ductal carcinoma in situ (DCIS) associated with microcalcifications in breast-conserving therapy (BCT). The aim of this study is to evaluate whether the radiological underestimation of tumor size has an influence on the histopathological margin status. Methods: Patients who underwent BCT with preoperatively diagnosed pure DCIS were included (pooled analysis of two trials). Multiple factors were analysed regarding radiological underestimation ≥10 mm. Radiological underestimation was defined as mammographic minus histological tumor size in mm. Results: Positive margins occurred in 75 of 189 patients. Radiological underestimation ≥10 mm was an independent influencing factor (OR 5.80; 95%CI 2.55–13.17; p < 0.001). A radiological underestimation was seen in 70 patients. The following parameters were statistically significant associated with underestimation: pleomorphic microcalcifications (OR 3.77; 95%CI 1.27–11.18), clustered distribution patterns (OR 4.26; 95%CI 2.25–8.07), and mammographic tumor sizes ≤20 mm (OR 7.47; 95%CI 3.49–15.99). Only a mammographic tumor size ≤20 mm was an independent risk factor (OR 6.49; 95%CI 2.30–18.26; p < 0.001). Grading, estrogen receptor status, and comedo necrosis did not influence the size estimation. Conclusion: Radiological underestimation is an independent risk factor for positive margins in BCT of DCIS associated with microcalcifications predominantly occurring in mammographic small tumors.